These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23832542)

  • 21. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis.
    Zhou X; Gu Y; Zhang SL
    Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.
    Ebid GT; Sedhom IA; El-Gammal MM; Moneer MM
    Asian Pac J Cancer Prev; 2012; 13(9):4315-20. PubMed ID: 23167335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis.
    Ding B; Sun W; Han S; Cai Y; Ren M; Shen Y
    Medicine (Baltimore); 2018 Mar; 97(13):e0210. PubMed ID: 29595663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
    Liu ZH; Bao ED
    Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
    Wei X; Chen D; Lv T
    Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis.
    Lu JT; Deng AP; Song J; Zhang L; Luo J
    Oncotarget; 2017 Mar; 8(13):21599-21608. PubMed ID: 28423490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.
    Huang Y; Chen H; Wang J; Bunjhoo H; Xiong W; Xu Y; Zhao J
    Gene; 2013 Jul; 524(1):54-8. PubMed ID: 23612252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.
    Mao D; Zhang Y; Lu H; Fu X
    Tumour Biol; 2013 Oct; 34(5):2529-38. PubMed ID: 23857281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene polymorphism of XRCC1 Arg399Gln and cervical carcinoma susceptibility in Asians: a meta-analysis based on 1,759 cases and 2,497 controls.
    Liu YT; Shi JP; Fu LY; Zhou B; Wang HL; Wu XM
    Asian Pac J Cancer Prev; 2013; 14(1):189-93. PubMed ID: 23534722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY; Zheng R; Guo C; Niu YM
    Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study.
    Liu F; Wei YG; Luo LM; Wang WT; Yan LN; Wen TF; Xu MQ; Yang JY; Li B
    Int J Cancer; 2013 May; 132(9):2056-64. PubMed ID: 23034899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Li T; Huang H; Liao D; Ling H; Su B; Cai M
    Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
    Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
    BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk.
    Cai K; Wang Y; Zhao X; Bao X
    Tumour Biol; 2014 Mar; 35(3):1891-7. PubMed ID: 24114013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis.
    Sun Y; Lu Y; Pen Q; Li T; Xie L; Deng Y; Qin A
    Tumour Biol; 2015 Jun; 36(6):4555-64. PubMed ID: 25649976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative assessment of the associations between CD28 T > C polymorphism (rs3116496) and cancer risk.
    Cong J; Zhang S; Gao X
    Tumour Biol; 2014 Sep; 35(9):9195-200. PubMed ID: 24927673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
    Wu K; Su D; Lin K; Luo J; Au WW
    Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.